Leerink Partners analyst Andrew Berens reiterated a Buy rating on Cullinan Management (CGEM – Research Report) yesterday and set a price target ...

On Monday, Cardinal Health Inc (CAH) stock saw a modest uptick, ending the day at $120.03 which represents a slight increase of $1.25 or 1.05% from the prior close of $118.78. The stock opened at $118 ...

On Monday, Fulcrum Therapeutics Inc (FULC) stock saw a modest uptick, ending the day at $3.03 which represents a slight increase of $0.02 or 0.66% from the prior close of $3.01. The stock opened at $3 ...

Aclaris Therapeutics has secured an exclusive licence from Biosion for the global rights to two new antibodies, BSI-045B and ...

Leerink Partners upgraded Aclaris from Market Perform to Outperform, with a price target of $7, up from $2. The analyst ...

Lilly’s muvalaplin is the first oral drug to show positive Phase II findings for Lp(a) reduction, eliciting up to an 86% drop ...

Equities researchers at Leerink Partnrs reduced their FY2024 earnings per share estimates for shares of Lexeo Therapeutics in ...

The good news from Monday’s results, according to Leerink Partners’ David Risinger, is that icotrokinra’s efficacy seems ...

Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...

CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...

CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the ...

Research analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of Ardent Health Partners in a ...